One week later. Subject Alpha-0's state had deteriorated further. Its movements were now jerky, fueled by a primal desperation, though its massive form continued to pace the arid confines of its climate-controlled cell, honing its combat instincts even in its weakened state.
Lina, working with intense precision, supervised android bots administering minute, controlled doses of various human blood types, including the exceptionally rare Rh-null. Each micro-injection was followed by immediate, granular biometric and neurological monitoring. She meticulously tracked any differential response, any specific "trigger" or preference that might exist even within such an extreme physiological dependency.
